News Research Research and Publications

Type 1 diabetes treatment may stem from outsmarting immune cells

Cory Berkland plans to research the use of proinsulin as a potential new treatment for Type 1 diabetes with a $2.6 million grant from The Leona M. and Harry B. Helmsley Charitable Trust. (Photo: iStock)
View Content

Type 1 diabetes — one of the most common chronic diseases in children — destroys insulin-producing cells in the pancreas, requiring lifelong daily management. The autoimmune disease affects up to 10% of people with diabetes worldwide.